postoperative aspiration pneumonia among adults using glp-1 receptor agonists How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Potential Use of GLP-1 and

Neurodegenerative diseases, including Alzheimers Disease (AD) and Parkinsons Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system

Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health care spending.

How do they work

Muscle Loss with GLP-1 Medications: What You Need to Know

In clinical practice, drug selection should therefore prioritize factors such as tolerability, safety profile, adherence, cost, and patient preference rather than expecting major differences in cardiovascular efficacy.